Athira shareholders approve reverse stock split at 2025 annual meeting

LeonaBio, Inc.

All three Class II director nominees elected: Joseph Edelman, John M. Fluke Jr., Grant Pickering.
Ratification of Ernst & Young as independent auditor approved (26,981,568 for).
Proposal to authorize reverse stock split approved (21,915,867 for, 4,835,818 against).
Board may set final split ratio from 5:1 to 20:1 in its discretion.
Quorum of 71.58% of shares present at the meeting.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.